Cymabay Therapeu Price on June 21, 2018

CBAYDelisted Stock  USD 32.48  0.01  0.03%   
If you're considering investing in Cymabay Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cymabay Therapeu stands at 32.48, as last reported on the 28th of March, with the highest price reaching 32.50 and the lowest price hitting 32.48 during the day. Cymabay Therapeu appears to be not too volatile, given 3 months investment horizon. Cymabay Therapeu secures Sharpe Ratio (or Efficiency) of 0.17, which signifies that the company had a 0.17% return per unit of risk over the last 3 months. By analyzing Cymabay Therapeu's technical indicators, you can evaluate if the expected return of 0.61% is justified by implied risk. Please makes use of Cymabay Therapeu's Risk Adjusted Performance of 0.1092, mean deviation of 1.79, and Downside Deviation of 1.69 to double-check if our risk estimates are consistent with your expectations.
  
Cymabay Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1651

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsCBAY
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.69
  actual daily
32
68% of assets are more volatile

Expected Return

 0.61
  actual daily
12
88% of assets have higher returns

Risk-Adjusted Return

 0.17
  actual daily
12
88% of assets perform better
Based on monthly moving average Cymabay Therapeu is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cymabay Therapeu by adding it to a well-diversified portfolio.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

About Cymabay Therapeu Stock history

Cymabay Therapeu investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cymabay is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cymabay Therapeu will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cymabay Therapeu stock prices may prove useful in developing a viable investing in Cymabay Therapeu
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California. Cymabay Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.

Cymabay Therapeu Stock Technical Analysis

Cymabay Therapeu technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Cymabay Therapeu technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cymabay Therapeu trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Cymabay Therapeu Period Price Range

Cymabay Therapeu March 28, 2024 Market Strength

Market strength indicators help investors to evaluate how Cymabay Therapeu stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cymabay Therapeu shares will generate the highest return on investment. By undertsting and applying Cymabay Therapeu stock market strength indicators, traders can identify Cymabay Therapeu entry and exit signals to maximize returns

Cymabay Therapeu Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Cymabay Therapeu's price direction in advance. Along with the technical and fundamental analysis of Cymabay Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cymabay to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cymabay Therapeu. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the Cymabay Therapeu information on this page should be used as a complementary analysis to other Cymabay Therapeu's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Consideration for investing in Cymabay Stock

If you are still planning to invest in Cymabay Therapeu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cymabay Therapeu's history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stocks Directory
Find actively traded stocks across global markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Transaction History
View history of all your transactions and understand their impact on performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum